114 related articles for article (PubMed ID: 10914056)
1. Veno-occlusive disease of the liver associated with thiopurines in a child with acute lymphoblastic leukemia.
Merino JM; Casanova F; Sáez-Royuela F; Velasco A; González JB
Pediatr Hematol Oncol; 2000; 17(5):429-31. PubMed ID: 10914056
[No Abstract] [Full Text] [Related]
2. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
[TBL] [Abstract][Full Text] [Related]
4. [The treatment with prostaglandin E1 of a suspected hepatic veno-occlusive disease in a leukemic patient].
Sculier JP; Bron D
Rev Med Brux; 1988 Oct; 9(7-8):398-400. PubMed ID: 3187257
[No Abstract] [Full Text] [Related]
5. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
[TBL] [Abstract][Full Text] [Related]
6. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
[TBL] [Abstract][Full Text] [Related]
7. Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Sahoo RK; Sharma A
Pediatr Blood Cancer; 2011 Oct; 57(4):700. PubMed ID: 21656901
[No Abstract] [Full Text] [Related]
8. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
[No Abstract] [Full Text] [Related]
9. Symptomatic hypoglycemia: an unusual side effect of oral purine analogues for treatment of ALL.
Bay A; Oner AF; Cesur Y; Dogan M; Etlik O; Sanli F
Pediatr Blood Cancer; 2006 Sep; 47(3):330-1. PubMed ID: 16047348
[TBL] [Abstract][Full Text] [Related]
10. Nuclear winter.
Lesesve JF; Mansuy L
Transfusion; 2005 Sep; 45(9):1403. PubMed ID: 16131370
[No Abstract] [Full Text] [Related]
11. Veno-occlusive disease of the liver induced by low-dose cyclophosphamide.
Modzelewski JR; Daeschner C; Joshi VV; Mullick FG; Ishak KG
Mod Pathol; 1994 Dec; 7(9):967-72. PubMed ID: 7892168
[TBL] [Abstract][Full Text] [Related]
12. Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
McNerney KO; Vasquez JC; Kent MW; McNamara JM
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e454-e455. PubMed ID: 28085749
[TBL] [Abstract][Full Text] [Related]
13. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
14. Acute lymphoblastic leukemia presenting in fulminant hepatic failure.
Litten JB; Rodríguez MM; Maniaci V
Pediatr Blood Cancer; 2006 Nov; 47(6):842-5. PubMed ID: 16106432
[TBL] [Abstract][Full Text] [Related]
15. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
[TBL] [Abstract][Full Text] [Related]
16. Reduction in bioavailability of 6-mercaptopurine on simultaneous administration with cow's milk.
Sofianou-Katsoulis A; Khakoo G; Kaczmarski R
Pediatr Hematol Oncol; 2006 Sep; 23(6):485-7. PubMed ID: 16849279
[TBL] [Abstract][Full Text] [Related]
17. Childhood acute lymphoblastic leukemia presenting with severe hepatic dysfunction.
Belgaumi AF; Hudson MM
Med Pediatr Oncol; 2001 Aug; 37(2):142-4. PubMed ID: 11496355
[No Abstract] [Full Text] [Related]
18. Sinusoidal Obstruction Syndrome of the Liver Associated With 6-Mercaptopurine During Maintenance in a Child With T-cell Acute Lymphoblastic Leukemia.
Prudowsky ZD; Schafer ES; Brackett J; Herbison AB; Shapiro MC
J Pediatr Hematol Oncol; 2023 Jan; 45(1):e121-e123. PubMed ID: 36036518
[TBL] [Abstract][Full Text] [Related]
19. Decreased activity of clotting factor V during ALL consolidation treatment with mercaptopurine in a child.
Vignand C; Couillault G; Jolimoy G; Dutrillaux F; Sgro C
Ann Pharmacother; 2006 Oct; 40(10):1887-8. PubMed ID: 16954327
[No Abstract] [Full Text] [Related]
20. Preventing toxicity with a gene test.
Marshall E
Science; 2003 Oct; 302(5645):588-90. PubMed ID: 14576416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
